OICHARTS
8 AMThe 8 AM report →

PHARMABEES

Nippon India Nifty Pharma ETF · NSE · INF204KC1089 · 272 sessions on record
₹27.11▼ −0.21 · −0.8%from ₹27.32 the session before · 1 Oct 2026 close · NSE end of day
Open
₹28.00
High
₹28.00
Low
₹26.76
Day's range
₹1.24.5% of the previous close
VWAP
₹27.04close +0.26% from it
Volume, shares
66 L1.52× the 20-session average
Turnover, ₹ crore
18
Trades
16,000410 shares per trade
Previous close
₹27.32−0.21 to the close
Price band, next session
₹24.40 – ₹29.8010% either side of the close · dynamic, widened in 5% steps when hit
Day range28% of the way up
₹26.76₹28.00
52-week range79% of the way up
₹21.69 2 Apr₹28.58 24 Sept

−5.1% from the high · +25% from the low

The fund

net asset value from AMFI · 1 Oct 2026

Nippon India Nifty Pharma ETF is an equity index fund from Nippon India Mutual Fund. It closed at ₹27.11 against a net asset value of ₹27.05 on the same day, a premium of +0.21%.

Net asset value
₹27.05published 1 Oct 2026
Premium to value
+0.21%close and value of 1 Oct 2026
Fund house
Nippon India Mutual Fund
Asset class
Equity indexOpen Ended Schemes(Other Scheme - Other ETFs)
How it has traded against value271 sessions where both a close and a value were published
Average gap
+0.01%over the window
Days above value
53%143 of 271 sessions
Widest premium
+1.4%19 Mar 2026
Widest discount
−1.3%1 Apr 2026

An exchange traded fund is worth what it holds, but it trades at what the market pays for it. A persistent premium means buyers are paying above the holdings; a discount means the opposite. Value is published once a day by the fund house, after the close.

Price history

272 sessions on record · to 1 Oct · NSE end of day

PHARMABEES is −1.6% over 20 sessions against Nifty's −6.2%, 5.1% below its 52-week high, realised volatility 13% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹PHARMABEES %Nifty 50 %Difference pp
250 sessionssince 26 Sept₹22.05▲ +23%▼ −9.1%+32
120 sessionssince 9 Apr₹22.74▲ +19%▼ −5.7%+25
60 sessionssince 8 Jul₹26.16▲ +3.6%▼ −6.1%+9.7
20 sessionssince 2 Sept₹27.56▼ −1.6%▼ −6.2%+4.6
5 sessionssince 24 Sept₹27.80▼ −2.5%▼ −2.8%+0.30
1 sessionsince 30 Sept₹27.32▼ −0.77%▼ −0.88%+0.11
Averages of the closeclose against each average
5-session average
₹27.52close −1.5% from it
20-session average
₹27.46close −1.3% from it
50-session average
₹27.31close −0.73% from it
200-session average
₹24.80close +9.3% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹0.913.3% of the close
Average day's range, 20
₹0.833.1% of the close
Volume against 20 sessions
1.52×66 L vs 44 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
13%≈ ±0.83% a session · moved more than that on 8 of 20
Realised volatility, 60
11%≈ ±0.72% a session · moved more than that on 20 of 60
Realised volatility, 250
13%≈ ±0.85% a session · moved more than that on 58 of 250
Beta to Nifty, 60
0.40moved with Nifty on 34 of 60 sessions
Beta to Nifty, 250
0.48moved with Nifty on 165 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
9 up · 10 downof 19
Last 60 sessions
32 up · 26 downof 58
Last 250 sessions
125 up · 118 downof 243
Best session, 250
▲ +3.0%3 Feb
Worst session, 250
▼ −2.2%1 Apr

0 bulletins on PHARMABEES

The desk has not written about Nippon India Nifty Pharma ETF yet. The tape carries every bulletin as it is published.

About Nippon India Nifty Pharma ETF

scheme records as published by AMFI
Scheme
Nippon India Nifty Pharma ETF
Fund house
Nippon India Mutual Fund
Asset class
Equity index · Open Ended Schemes(Other Scheme - Other ETFs)
Exchange
NSE · trades like a share, settles like a fund
ISIN
INF204KC1089
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Net asset value
AMFI daily scheme report · published each evening by the fund house
Computed
2 Oct, 01:04 am IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.